Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chugai Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥11.15T | 28.7x | 1.92 | JP¥6,805 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.7% Upside | Upgrade to Pro+ | |
Daiichi Sankyo | Tokyo | Healthcare | Pharmaceuticals | JP¥8.66T | 35.2x | 0.51 | JP¥4,590 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.3% Upside | Upgrade to Pro+ | |
Takeda Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥6.54T | 22.4x | 0.45 | JP¥4,126 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15% Upside | Upgrade to Pro+ | |
Otsuka Holdings Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥4.72T | 31.3x | -1.75 | JP¥8,784 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.3% Upside | Upgrade to Pro+ | |
Astellas Pharma Inc. | Tokyo | Healthcare | Pharmaceuticals | JP¥2.83T | 51.8x | 1.15 | JP¥1,582.50 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.5% Upside | Upgrade to Pro+ | |
Shionogi | Tokyo | Healthcare | Pharmaceuticals | JP¥1.87T | 12.2x | -0.45 | JP¥2,206 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12% Upside | Upgrade to Pro+ | |
Kyowa Kirin | Tokyo | Healthcare | Pharmaceuticals | JP¥1.28T | 16x | 0.33 | JP¥2,508 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.5% Upside | Upgrade to Pro+ | |
Eisai | Tokyo | Healthcare | Pharmaceuticals | JP¥1.26T | 31.2x | -2.11 | JP¥4,470 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.3% Upside | Upgrade to Pro+ | |
Ono Pharmaceutical Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥809.07B | 8.6x | -0.4 | JP¥1,711 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.8% Upside | Upgrade to Pro+ | |
Rohto Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥642.21B | 23.5x | -2.79 | JP¥2,815 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.6% Upside | Upgrade to Pro+ | |
Santen Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥587.59B | 23.4x | 4.5 | JP¥1,711 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.1% Upside | Upgrade to Pro+ | |
Medipal Holdings Corp | Tokyo | Healthcare | Pharmaceuticals | JP¥502.62B | 11x | 0.54 | JP¥2,420.50 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.1% Upside | Upgrade to Pro+ | |
Tsumura & Co | Tokyo | Healthcare | Pharmaceuticals | JP¥370.4B | 14.7x | 0.17 | JP¥4,882 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.3% Upside | Upgrade to Pro+ | |
Suzuken Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥366.82B | 11.1x | 0.27 | JP¥4,710 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.8% Upside | Upgrade to Pro+ | |
Hisamitsu Pharmaceutical Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥308.92B | 21.6x | 1.8 | JP¥4,210 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.1% Upside | Upgrade to Pro+ | |
Nippon Shinyaku | Tokyo | Healthcare | Pharmaceuticals | JP¥284.34B | 10.9x | 1.14 | JP¥4,225 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.7% Downside | Upgrade to Pro+ | |
Toho Holdings | Tokyo | Healthcare | Pharmaceuticals | JP¥277.6B | 15.7x | -2.82 | JP¥4,302 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.1% Downside | Upgrade to Pro+ | |
Sawai Group Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥250.54B | 11.1x | 0.18 | JP¥2,052.50 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.7% Upside | Upgrade to Pro+ | |
Sumitomo Dainippon Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥229.63B | -0.8x | 0.01 | JP¥577 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.6% Downside | Upgrade to Pro+ | |
Kaken Pharmaceutical Co Ltd | Tokyo | Healthcare | Pharmaceuticals | JP¥166B | 9.1x | 0.02 | JP¥4,382 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.9% Upside | Upgrade to Pro+ | |
Kissei Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥153.46B | 14.8x | -1.04 | JP¥3,575 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.3% Upside | Upgrade to Pro+ | |
Towa Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥139.31B | 8.8x | 0.06 | JP¥2,824 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.1% Upside | Upgrade to Pro+ | |
Torii Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥129.7B | 24.6x | 0.47 | JP¥4,605 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.2% Downside | Upgrade to Pro+ | |
Mochida Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥127.45B | 28.1x | -1.74 | JP¥3,605 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11.2% Downside | Upgrade to Pro+ | |
Zeria Pharmaceutical | Tokyo | Healthcare | Pharmaceuticals | JP¥107.16B | 12.8x | 1.18 | JP¥2,435 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.2% Upside | Upgrade to Pro+ | |
Nxera Pharma | Tokyo | Healthcare | Pharmaceuticals | JP¥100.69B | -26.7x | 11.53 | JP¥1,118 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kyorin Holdings Inc | Tokyo | Healthcare | Pharmaceuticals | JP¥85.31B | 17.7x | -2.15 | JP¥1,483 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.9% Downside | Upgrade to Pro+ | |
JCR Pharmaceuticals | Tokyo | Healthcare | Pharmaceuticals | JP¥82.23B | -193.4x | 1.9 | JP¥672 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.9% Downside | Upgrade to Pro+ | |
Katakura Industries | Tokyo | Healthcare | Pharmaceuticals | JP¥63.99B | 22.6x | -1.31 | JP¥1,982 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ASKA Pharmaceutical Holdings Co | Tokyo | Healthcare | Pharmaceuticals | JP¥58.37B | 9.8x | -10.59 | JP¥2,059 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.2% Upside | Upgrade to Pro+ |